Literature DB >> 28250047

Effectiveness of job rotation for preventing work-related musculoskeletal diseases: a cluster randomised controlled trial.

Maria Luiza Caires Comper1,2, Jack Tigh Dennerlein3,4, Gabriela Dos Santos Evangelista2, Patricia Rodrigues da Silva5, Rosimeire Simprini Padula1,5.   

Abstract

OBJECTIVE: Job rotation is an organisational strategy widely used on assembly lines in manufacturing industries to mitigate workers' exposure so as to prevent musculoskeletal disorders. This study aimed to evaluate the effectiveness of job rotation for reducing working hours lost due to sick leave resulting from musculoskeletal diseases.
METHODS: The design consisted of a 1-year cluster randomised controlled trial with a blinded assessor. Production sectors of the textile industry were randomised to intervention and control groups. Both groups received ergonomic training. The intervention group performed a job rotation programme. The primary outcome measure was number of working hours lost due to sick leave as a result of musculoskeletal disease (ICD-10). The secondary outcome measures were musculoskeletal symptoms (Yes/No), risk factors for musculoskeletal diseases (0-10), psychosocial factors and fatigue (0-100), general health (0-100), and productivity (0-10). All secondary outcomes were measured at baseline and 12-month follow-up.
RESULTS: At the 12-month follow-up, both groups showed an increase in the number of working hours lost due to sick leave for musculoskeletal disease. There was no significant difference between the job rotation intervention group (mean deviation -5.6 hours, 95% CI -25.0 to 13.8) at the 12-month follow-up and the control group. There were no significant differences between groups for the secondary outcomes (p>0.05).
CONCLUSIONS: The job rotation programme was not effective in reducing the number of working hours lost due to sick leave, decreasing the prevalence of musculoskeletal symptoms, or improving perception of musculoskeletal pain and workplace risk factors, psychosocial risk factors and productivity. TRIAL REGISTRATION NUMBER: NCT01979731. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Industrial Workers; Job design; Physical exposure; task rotation

Mesh:

Year:  2017        PMID: 28250047     DOI: 10.1136/oemed-2016-104077

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  6 in total

1.  Relationship between job rotation and work-related low back pain: a cross-sectional study using data from the fifth Korean working conditions survey.

Authors:  Ji-Su Shin; Kwanghyun Seo; Hyun-Jeong Oh; MyeongSeob Lim; Hee-Tae Kang; Kyeong-Sook Jeong; Sang-Baek Koh; Sung-Kyung Kim; Sung-Soo Oh
Journal:  Ann Occup Environ Med       Date:  2021-01-28

2.  More Hype Than Substance? A Meta-Analysis on Job and Task Rotation.

Authors:  Lisa Mlekus; Günter W Maier
Journal:  Front Psychol       Date:  2021-03-25

3.  Trends in Work-Related Musculoskeletal Disorders From the 2002 to 2014 General Social Survey, Quality of Work Life Supplement.

Authors:  Robert B Dick; Brian D Lowe; Ming-Lun Lu; Edward F Krieg
Journal:  J Occup Environ Med       Date:  2020-08       Impact factor: 2.306

4.  Designing industrial work to be 'just right' to promote health - a study protocol for a goldilocks work intervention.

Authors:  Anders Fritz Lerche; Svend Erik Mathiassen; Charlotte Lund Rasmussen; Leon Straker; Karen Søgaard; Andreas Holtermann
Journal:  BMC Public Health       Date:  2022-02-23       Impact factor: 3.295

5.  Evaluating the Effect of Supported Systematic Work Environment Management During the COVID-19 Pandemic: Protocol for a Mixed Methods Study.

Authors:  Patrik Haraldsson; Axel Ros; Dirk Jonker; Kristina Areskoug Josefsson
Journal:  JMIR Res Protoc       Date:  2022-03-10

Review 6.  Sleep, Health and Wellness at Work: A Scoping Review.

Authors:  Nicola Magnavita; Sergio Garbarino
Journal:  Int J Environ Res Public Health       Date:  2017-11-06       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.